Aamna Shah

• Managed a portfolio of 30+ high-profile health systems and hospitals, serving as a trusted advisor to C-suite executives, investors, and industry leaders on financial health and credit risk.

• Led end-to-end implementation and execution of credit rating assessments, ensuring timely and accurate analysis that influenced multi-million-dollar investment decisions.

• Developed structured risk assessment frameworks, streamlining data evaluation, and improving transparency for internal and external stakeholders.

• Served as a key representative of S&P Global Ratings, managing relationships with issuers, investors, and regulatory stakeholders, while leading credit committees, addressing media inquiries, and presenting insights at industry conferences and webinars.

• Trained and mentored junior analysts, equipping them with skills in client engagement, market analysis, and executive presentation.

• Led the development and deployment of analytics-driven product implementation strategies, overseeing execution across a portfolio of 45+ healthcare products.

• Identified key inefficiencies in product rollout and adoption, building consensus across 10+ cross-functional teams to implement solutions that reduced time-to-market and improved engagement.

• Established trusted partnerships with sales, actuarial, underwriting, and analytics leadership to ensure seamless data integration, improving customer satisfaction by 15%.

• Designed and executed a scalable analytics framework, enhancing real-time tracking of key performance indicators and aligning business strategy with operational execution.

• Provided high-level reporting and insights to senior leadership, driving strategic decisions that improved market positioning and revenue growth.

• Led multiple high-visibility, cross-functional implementations across Blue Plans, partnering with senior leadership and external stakeholders to scale and operationalize clinical innovation initiatives.

• Designed and launched a Medicare Stars performance improvement program, leading to 80% adoption among 15 participating Blue Plans, significantly enhancing financial outcomes and operational performance.

• Conducted data-driven assessments of market trends and emerging healthcare risks, leveraging insights to implement rapid-response initiatives that addressed medical and pharmacy management challenges.

• Served as a subject matter expert in behavioral economics and Medicare Stars, providing strategic recommendations and presenting insights at industry events and internal leadership forums.

• Built and maintained strong relationships with healthcare executives, industry groups, and regulatory stakeholders, fostering alignment and driving process improvements.